Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP431595.RAQX8AWeOLgzI3l8LZ8-x3jpBeWJYV4jzIaub5MfkD168130_assertion description "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431595.RAQX8AWeOLgzI3l8LZ8-x3jpBeWJYV4jzIaub5MfkD168130_provenance.
• NP208806.RAoS69hlzfTbuVR5lIdROuqHv5WrWMBAVHFzyGpZeRZjg130_assertion description "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208806.RAoS69hlzfTbuVR5lIdROuqHv5WrWMBAVHFzyGpZeRZjg130_provenance.
• NP598705.RAV_Ayje5EVJaTxxdwK9K5de9dFG8W7yrIfGviWGqSfHw130_assertion description "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598705.RAV_Ayje5EVJaTxxdwK9K5de9dFG8W7yrIfGviWGqSfHw130_provenance.
• NP918908.RABg96dgl4dZcJZf1yAFrZgjzvRfoy4a35PYZoxn4w3v0130_assertion description "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918908.RABg96dgl4dZcJZf1yAFrZgjzvRfoy4a35PYZoxn4w3v0130_provenance.
• NP591304.RAK77_aGyetbbjQ47HD6NXVtCh37ZYlRs9tm_RX7hruSg130_assertion description "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591304.RAK77_aGyetbbjQ47HD6NXVtCh37ZYlRs9tm_RX7hruSg130_provenance.
• NP629288.RAHIOL1sF-AtkgpX6Vux2XwwKxY_K52Kq7IVupETKSVFY130_assertion description "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629288.RAHIOL1sF-AtkgpX6Vux2XwwKxY_K52Kq7IVupETKSVFY130_provenance.
• NP912796.RALGiOUKjfm3TFeAfkyKLGj7Ow6OHSQZ9GNO1y45Tro24130_assertion description "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912796.RALGiOUKjfm3TFeAfkyKLGj7Ow6OHSQZ9GNO1y45Tro24130_provenance.
• assertion description "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP905146.RAPzesCIs7G9VavSBaxbwIoayTzw43plXkvNbSm91pWyI130_assertion description "[We conclude that the expression pattern of OCT2, SSX2-4, and SAGE1 supports the origin of SS from spermatogonia and provides new evidence for heterogeneity of this tumour, potentially linked either to the cellular origin of SS or to partial differentiation during tumour progression, including a hitherto unknown OCT2-positive variant of the tumour likely derived from A(dark) spermatogonia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905146.RAPzesCIs7G9VavSBaxbwIoayTzw43plXkvNbSm91pWyI130_provenance.